Head and neck cancers affect the mouth, throat, larynx, and more, with early detection being crucial for better survival chances. Key early symptoms include persistent sore throat, voice changes, ...
HNSCC, whereas the combination of durvalumab and cetuximab showed limited success. Abenacianine received fast track designation for lung cancer surgery, the combination of amivantamab and Lazertinib ...
The American Association for Cancer Research says four percent of all cancers in the U.S. are types of head and neck cancers. Catching it early is key.